FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2760458591> ?p ?o ?g. }

• W2760458591 endingPage "6217" @default.
• W2760458591 startingPage "6208" @default.
• W2760458591 abstract "The use of viral vectors in heterologous prime-boost regimens to induce potent T cell responses in addition to humoral immunity is a promising vaccination strategy in the fight against malaria. We conducted an open-label, first-in-human, controlled Phase I study evaluating the safety and immunogenicity of Matrix-M adjuvanted vaccination with a chimpanzee adenovirus serotype 63 (ChAd63) prime followed by a modified vaccinia Ankara (MVA) boost eight weeks later, both encoding the malaria ME-TRAP antigenic sequence (a multiple epitope string fused to thrombospondin-related adhesion protein). Twenty-two healthy adults were vaccinated intramuscularly with either ChAd63-MVA ME-TRAP alone (n=6) or adjuvanted with 25μg (n=8) or 50μg (n=8) Matrix-M. Vaccinations appeared to be safe and generally well tolerated, with the majority of local and systemic adverse events being mild in nature. The addition of Matrix-M to the vaccine did not increase local reactogenicity; however, systemic adverse events were reported more frequently by volunteers who received adjuvanted vaccine in comparison to the control group. T cell ELISpot responses peaked at 7-days post boost vaccination with MVA ME-TRAP in all three groups. TRAP-specific IgG responses were highest at 28-days post boost with MVA ME-TRAP in all three groups. There were no differences in cellular and humoral immunogenicity at any of the time points between the control group and the adjuvanted groups. We demonstrate that Matrix-M can be safely used in combination with ChAd63-MVA ME-TRAP heterologous prime-boost immunization without any reduction in cellular or humoral immunogenicity. Clinical Trials Registration NCT01669512." @default.
• W2760458591 created "2017-10-06" @default.
• W2760458591 creator A5005164111 @default.
• W2760458591 creator A5033735799 @default.
• W2760458591 creator A5037138357 @default.
• W2760458591 creator A5038203672 @default.
• W2760458591 creator A5040896653 @default.
• W2760458591 creator A5044551272 @default.
• W2760458591 creator A5048193217 @default.
• W2760458591 creator A5061980742 @default.
• W2760458591 creator A5075219586 @default.
• W2760458591 creator A5077593319 @default.
• W2760458591 creator A5088908508 @default.
• W2760458591 date "2017-10-01" @default.
• W2760458591 modified "2023-10-13" @default.
• W2760458591 title "Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™" @default.
• W2760458591 cites W1532851064 @default.
• W2760458591 cites W1904140959 @default.
• W2760458591 cites W1959011380 @default.
• W2760458591 cites W1971747284 @default.
• W2760458591 cites W1973228533 @default.
• W2760458591 cites W2002833434 @default.
• W2760458591 cites W2012973954 @default.
• W2760458591 cites W2014916785 @default.
• W2760458591 cites W2030388818 @default.
• W2760458591 cites W2047717992 @default.
• W2760458591 cites W2051842777 @default.
• W2760458591 cites W2063937996 @default.
• W2760458591 cites W2073557509 @default.
• W2760458591 cites W2105595963 @default.
• W2760458591 cites W2108476551 @default.
• W2760458591 cites W2130629422 @default.
• W2760458591 cites W2135487927 @default.
• W2760458591 cites W2151497677 @default.
• W2760458591 cites W2151784087 @default.
• W2760458591 cites W2194742159 @default.
• W2760458591 cites W2244674613 @default.
• W2760458591 cites W2286448385 @default.
• W2760458591 cites W2329293616 @default.
• W2760458591 cites W2343475147 @default.
• W2760458591 cites W2346540416 @default.
• W2760458591 cites W2409854390 @default.
• W2760458591 cites W2496132145 @default.
• W2760458591 cites W2577477566 @default.
• W2760458591 cites W4254848468 @default.
• W2760458591 cites W65828984 @default.
• W2760458591 cites W919679318 @default.
• W2760458591 doi "https://doi.org/10.1016/j.vaccine.2017.09.028" @default.
• W2760458591 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28941620" @default.
• W2760458591 hasPublicationYear "2017" @default.
• W2760458591 type Work @default.
• W2760458591 sameAs 2760458591 @default.
• W2760458591 citedByCount "26" @default.
• W2760458591 countsByYear W27604585912018 @default.
• W2760458591 countsByYear W27604585912019 @default.
• W2760458591 countsByYear W27604585912020 @default.
• W2760458591 countsByYear W27604585912021 @default.
• W2760458591 countsByYear W27604585912022 @default.
• W2760458591 countsByYear W27604585912023 @default.
• W2760458591 crossrefType "journal-article" @default.
• W2760458591 hasAuthorship W2760458591A5005164111 @default.
• W2760458591 hasAuthorship W2760458591A5033735799 @default.
• W2760458591 hasAuthorship W2760458591A5037138357 @default.
• W2760458591 hasAuthorship W2760458591A5038203672 @default.
• W2760458591 hasAuthorship W2760458591A5040896653 @default.
• W2760458591 hasAuthorship W2760458591A5044551272 @default.
• W2760458591 hasAuthorship W2760458591A5048193217 @default.
• W2760458591 hasAuthorship W2760458591A5061980742 @default.
• W2760458591 hasAuthorship W2760458591A5075219586 @default.
• W2760458591 hasAuthorship W2760458591A5077593319 @default.
• W2760458591 hasAuthorship W2760458591A5088908508 @default.
• W2760458591 hasConcept C104317684 @default.
• W2760458591 hasConcept C147483822 @default.
• W2760458591 hasConcept C159047783 @default.
• W2760458591 hasConcept C203014093 @default.
• W2760458591 hasConcept C22070199 @default.
• W2760458591 hasConcept C2777704310 @default.
• W2760458591 hasConcept C2780801004 @default.
• W2760458591 hasConcept C2780868878 @default.
• W2760458591 hasConcept C2781356689 @default.
• W2760458591 hasConcept C32470452 @default.
• W2760458591 hasConcept C40767141 @default.
• W2760458591 hasConcept C55493867 @default.
• W2760458591 hasConcept C71924100 @default.
• W2760458591 hasConcept C86803240 @default.
• W2760458591 hasConceptScore W2760458591C104317684 @default.
• W2760458591 hasConceptScore W2760458591C147483822 @default.
• W2760458591 hasConceptScore W2760458591C159047783 @default.
• W2760458591 hasConceptScore W2760458591C203014093 @default.
• W2760458591 hasConceptScore W2760458591C22070199 @default.
• W2760458591 hasConceptScore W2760458591C2777704310 @default.
• W2760458591 hasConceptScore W2760458591C2780801004 @default.
• W2760458591 hasConceptScore W2760458591C2780868878 @default.
• W2760458591 hasConceptScore W2760458591C2781356689 @default.
• W2760458591 hasConceptScore W2760458591C32470452 @default.
• W2760458591 hasConceptScore W2760458591C40767141 @default.
• W2760458591 hasConceptScore W2760458591C55493867 @default.
• W2760458591 hasConceptScore W2760458591C71924100 @default.

• next